United Therapeutics Corp (NASDAQ:UTHR)

172.86
Delayed Data
As of Jan 15
 +5.60 / +3.35%
Today’s Change
75.58
Today|||52-Week Range
173.72
+13.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.5B1.6B1.7B1.6B
 
 
 
 
 
Cost of Goods Sold36.1M41.1M74.7M162.8M
 
 
 
 
 
Depreciation And Amortization32.9M31.6M31.0M35.9M
 
 
 
 
 
 
Operating ExpensesGross Income1.4B1.5B1.6B1.4B
 
 
 
 
 
General Expenses697.7M464.4M594.7M618.3M
 
 
 
 
 
Research And Development245.1M147.6M264.6M357.9M
 
 
 
 
 
Total Operating Expenses766.7M537.1M700.4M817.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income699.0M1.1B1.0B810.8M
 
 
 
 
 
Extraordinary Charge0.000.00-259.6M-58.9M
 
 
 
Interest Expense On Debt4.7M3.9M9.0M13.9M
 
 
 
 
 
Other Expenses350.2M2.4M13.2M-7.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.0B1.1B769.5M758.9M
 
 
 
 
 
Income Taxes-392.8M-346.5M-351.6M-169.7M
 
 
 
 
 
Net Income651.6M713.7M417.9M589.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS46.0M43.8M44.0M43.5M
 
 
 
 
 
Shares To Calculate EPS Diluted51.2M46.8M44.9M44.0M
 
 
 
 
 
 
Earnings Per ShareEPS$12.72$15.25$9.31$13.39
 
 
 
 
 
EPS Diluted$12.72$15.25$9.31$13.39